Clinical Trial: A Randomized Trial of MODUCARE Versus Wait-and-See Approach for Histologically Proven Low-grade Cervical Intraepithelial Neoplasia (CIN1)

U.S., Feb. 3 -- ClinicalTrials.gov registry received information related to the study (NCT07379905) titled 'A Randomized Trial of MODUCARE Versus Wait-and-See Approach for Histologically Proven Low-grade Cervical Intraepithelial Neoplasia (CIN1)' on Jan. 25.

Brief Summary: MODUCIN-1 (MODUcare for CIN1) is a prospective, single center, open-label, randomized trial that its purpose is to compare MODUCARE versus Wait-and-See Approach for the regression rate of histologically proven low-grade Cervical Intraepithelial Neoplasia (CIN1).

Study Start Date: March 01

Study Type: INTERVENTIONAL

Condition: Low-grade Cervical Intraepithelial Neoplasia Moducare

Intervention: DIETARY_SUPPLEMENT: MODUCARE

MODUCARE is classified as a natural dietary...